Bio-Rad posts increased Q1 revenue during pandemic

By The Science Advisory Board staff writers

May 8, 2020 -- For the quarter revenue increased to $571.6 million, compared with $554 million in the first quarter of 2019. Meanwhile, net income in the first quarter plummeted to $685.9 million from approximately $865 million in the same quarter a year ago.

The company's President and CEO Norman Schwartz said he was pleased with the results given the impact of the COVID-19 pandemic.

BD revenues edge up for 2nd quarter
Becton Dickinson (BD) saw its revenues grow slightly for the second quarter, but the company withdrew its previously issued guidance due to fallout from...
Bio-Rad acquires single-cell analysis company
Bio-Rad Laboratories has acquired Celsee, a company that offers instruments and consumables for single-cell analysis.

Copyright © 2020 scienceboard.net


Conferences
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
Online
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter